Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT03948035

Active, not recruiting

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

Newly Diagnosed Multiple Myeloma
NCT04486508

Completed

Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 (INSPIRATION)

Covid19
NCT04355039

Withdrawn

INCB053914 and Pomalidomide With Dexamethasone for Relapsed and/or Refractory Multiple Myeloma

Refractory Multiple Myeloma | Relapse Multiple Myeloma
NCT00723255

Completed

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Recurrent Endometrial Carcinoma
NCT01133743

Completed

Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia
NCT01985477

Terminated

Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma

Myeloma
NCT01531998

Completed

Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)

Myeloma
NCT00749619

Completed

Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?

Hemodialysis | End Stage Renal Disease
NCT06523465

Recruiting

Statin Combined with Amlodipine Treats Primary Aldosteronism (STOP-PA)

Hypertension | Primary Aldosteronism | Mineralocorticoid Receptor Antagonist | Statin
NCT05348213

Recruiting

Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma (R-ICE+X)

Diffuse Large B Cell Lymphoma
NCT04850001

Recruiting

Cognitive Decline in Asymptomatic Intracranial Stenosis Patients: A 1-Year Follow-Up Study

Magnetic Resonance Imaging | Asymptomatic Intracranial Stenosis | Medical Treatment
NCT02446431

Recruiting

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence (Metronomic)

Solid Tumor
NCT02483247

Completed

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

Cancer
NCT00828009

Completed

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Lung Cancer
NCT00936832

Withdrawn

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

Colorectal Cancer | Metastatic Cancer
NCT01239797

Completed

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma (ELOQUENT - 2)

Lymphoma | Multiple Myeloma
NCT00423696

Completed

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer
NCT01212757

Completed

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PALACE2)

Psoriatic Arthritis
NCT02833948

Completed

Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) (GALILEO-4D)

Cardiovascular Diseases | Thrombosis | Aortic Valve Stenosis | Heart Valve Diseases | Ventricular Outflow Obstruction
NCT03601871

Unknown

The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy

Chemotherapy-induced Nausea and Vomiting
NCT00408408

Unknown

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Breast Cancer
NCT00856492

Completed

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Breast Cancer
NCT02341638

Completed

Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects

Thrombosis
NCT01029743

Completed

Xarelto Regulatory Post-Marketing Surveillance

Venous Thromboembolism
NCT02579564

Unknown

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Non Small Cell Lung Cancer | Malignant Hydrothorax
NCT00458705

Completed

Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
NCT02658838

Unknown

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

LOVASTATIN/TICAGRELOR [VA Drug Interaction]
NCT00910065

Completed

BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) (ACUTE)

Acute Coronary Syndrome
NCT01870466

Completed

Pharmacodynamic Drug Interaction Between Cilostazol and Statins (SMCCPT-100)

Healthy
NCT00253526

Withdrawn

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage II Pancreatic Cancer | Stage I Pancreatic Cancer
NCT00077298

Completed

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer
NCT02294643

Completed

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study (SERENADE)

Coronary Artery Disease | Diabetes Mellitus | Renal Insufficiency, Chronic
NCT01756989

Completed

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Brainstem Glioma
NCT00027703

Completed

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Recurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Localized Malignant Mesothelioma
NCT00805649

Completed

Combined Therapy in Age-Related Macular Degeneration (ARMD)

Age-Related Macular Degeneration
NCT00479362

Completed

Anticoagulant Therapy During Pacemaker Implantation (FINPAC)

Hemorrhage | Embolism | Thrombosis
NCT01004705

Terminated

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Elevated LDL Cholesterol
NCT01214941

Completed

Effect of Itraconazole and Ticlopidine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol

Pharmacokinetics | Pharmacodynamics
NCT07504835

Recruiting

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

Prostate Carcinoma
NCT06734468

Active, not recruiting

Personalized Approach to Promote Healthy Aging

Aging | Aging, Healthy
NCT06256718

Active, not recruiting

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Human Papillomavirus Infection
NCT07153744

Not yet recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction (MUST Ⅱ)

Acute Myocardial Infarction (AMI) | Percutaneous Coronary Intervention (PCI)
NCT06082063

Recruiting

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes (Steno1)

Cardiovascular Diseases | Heart Failure | Type 1 Diabetes | Kidney Failure
NCT05717738

Recruiting

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma (CCGLC-008)

Hepatocellular Carcinoma Non-resectable
NCT05644210

Recruiting

Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Antiphospholipid Syndrome
NCT05638867

Recruiting

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI

Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention
NCT05353140

Recruiting

LAAO Versus NOAC in Patients with AF and PCI

Atrial Fibrillation | Percutaneous Coronary Intervention
NCT03896737

Active, not recruiting

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

Multiple Myeloma
NCT04553692

Terminated

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

Sarcoma | Acute Myeloid Leukemia | Colorectal Cancer | Solid Tumor | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chondrosarcoma | Small Lymphocytic Lymphoma
NCT02542657

Active, not recruiting

Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma

Myeloma

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations